Phase 3 DEE Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
A Study of Buntanetap in Participants With PD
Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled27 locationsNCT07284784
Recruiting
Phase 3
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+3 more
University Hospital, Angers1,424 enrolled35 locationsNCT06195540
Recruiting
Phase 2Phase 3
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Deep Venous Thrombosis
Yale University258 enrolled22 locationsNCT04924322
Recruiting
Phase 3
Neuronavigation-assisted Stereotactic Puncture With Tenecteplase for Acute Intracerebral Hemorrhage
Deep Intracerebral Hemorrhage (ICH)
Beijing Tiantan Hospital732 enrolled1 locationNCT06868511
Terminated
Phase 3
MONITOR - MethOxyfluraNe in InTerventiOnal Radiology
Deep tissue core biopsyInsertion or removal of portacaths.
South Western Sydney Local Health District Human Research Ethics Committee322 enrolled1 locationACTRN12623001167651
Completed
Phase 3Phase 4
Assessment of microbleeding after prophylaxis with enoxaparin or rivaroxaban against venous thromboembolic disease following hip and knee surgery
Prevention and treatment of venous thromboembolism (VTE); comprising deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip and knee arthroplasty.
Launceston General Hospital1,060 enrolled1 locationACTRN12609000762257